Community share views on HIV vaccine trials
In line with World Aids Day, a landmark clinical trial to test whether a vaccine regimen can prevent HIV infection in the South African population, kicks off today.
The HVTN 702 vaccine trial in SA is currently the only HIV trial being conducted in the world.
SEE: Watch 1st person receive new HIV vaccine
In line with World Aids Day tomorrow, a landmark clinical trial to test whether a vaccine regimen can prevent HIV infection in the South African population, kicks off today.
Here’s what people are saying on Twitter:
Tomorrow is #WorldAidsDay which is held on the 1st December each year & is an opportunity to unite in the fight against HIV. ^eN4
— National Department of Health (@HealthZA) November 30, 2016
https://twitter.com/Arne_CCC/status/803950745406074880
Not at all. It is the most affected and infected continent in the world,only makes sense #HIVVACCINE #Poorbaba https://t.co/GoPvzdEDIv
— Ace Mashudu (@Acemashudu) November 30, 2016
Please note that this is not a cure. Don't start acting careless about your life. #HIVVaccine
— Primo Consultancy (@_consultprimo) November 30, 2016
"If an HIV vaccine were found to work in South Africa, it could dramatically alter the course of the pandemic,”… https://t.co/RVHx8XrYEs
— HVTN (@HelpEndHIV) November 29, 2016
